Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.

Yue, Cai; Li, Guanhong; Wen, Yubing; Li, Xuemei; Gao, Ruitong

Yue, Cai; Li, Guanhong; Wen, Yubing; Li, Xuemei; Gao, Ruitong.

Afiliación

Yue C; From the Department of Nephrology, Peking Union Medical College Hospital; Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Li G; C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, M
Wen Y; From the Department of Nephrology, Peking Union Medical College Hospital; Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Li X; C. Yue, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; G. Li, MD, Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; Y. Wen, M
Gao R; From the Department of Nephrology, Peking Union Medical College Hospital; Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

J Rheumatol ; 45(5): 655-662, 2018 05.

Article en En | MEDLINE | ID: mdl-29449503

Asunto(s)

Antagonistas de Receptores de Angiotensina/uso terapéutico; Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico; Anticuerpos Antifosfolípidos/sangre; Fosinopril/uso terapéutico; Lupus Eritematoso Sistémico/complicaciones; Nefritis Lúpica/complicaciones; Nefritis Lúpica/patología; Sistema Renina-Angiotensina/efectos de los fármacos; Adulto; Inhibidores de la Enzima Convertidora de Angiotensina/administración & dosificación; Biopsia; Distribución de Chi-Cuadrado; Progresión de la Enfermedad; Femenino; Estudios de Seguimiento; Fosinopril/administración & dosificación; Tasa de Filtración Glomerular/efectos de los fármacos; Humanos; Hipertensión/tratamiento farmacológico; Riñón/patología; Modelos Logísticos; Nefritis Lúpica/inmunología; Masculino; Persona de Mediana Edad; Modelos de Riesgos Proporcionales; Proteinuria/tratamiento farmacológico; Factores de Riesgo; Estadísticas no Paramétricas; Resultado del Tratamiento; Adulto Joven

Palabras clave

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIPHOSPHOLIPID SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sistema Renina-Angiotensina / Nefritis Lúpica / Inhibidores de la Enzima Convertidora de Angiotensina / Fosinopril / Anticuerpos Antifosfolípidos / Antagonistas de Receptores de Angiotensina / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Rheumatol Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google